KR20010015915A - 증강된 유전자 송달을 위한 핵산과 혈관작용제의 조합 - Google Patents

증강된 유전자 송달을 위한 핵산과 혈관작용제의 조합 Download PDF

Info

Publication number
KR20010015915A
KR20010015915A KR1020007008781A KR20007008781A KR20010015915A KR 20010015915 A KR20010015915 A KR 20010015915A KR 1020007008781 A KR1020007008781 A KR 1020007008781A KR 20007008781 A KR20007008781 A KR 20007008781A KR 20010015915 A KR20010015915 A KR 20010015915A
Authority
KR
South Korea
Prior art keywords
vector
histamine
fgf
injection
artery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020007008781A
Other languages
English (en)
Korean (ko)
Inventor
커크해몬드에이취.
Original Assignee
더 리젠츠 오브 더 유니버시티 오브 캘리포니아
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 filed Critical 더 리젠츠 오브 더 유니버시티 오브 캘리포니아
Publication of KR20010015915A publication Critical patent/KR20010015915A/ko
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0075—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the delivery route, e.g. oral, subcutaneous
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0083—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the administration regime
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Paints Or Removers (AREA)
KR1020007008781A 1998-02-11 1999-02-09 증강된 유전자 송달을 위한 핵산과 혈관작용제의 조합 Ceased KR20010015915A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2177398A 1998-02-11 1998-02-11
US09/021,773 1998-02-11
PCT/US1999/002702 WO1999040945A2 (en) 1998-02-11 1999-02-09 Combination of a nucleic acid and a vasoactive agent for enhanced gene delivery

Publications (1)

Publication Number Publication Date
KR20010015915A true KR20010015915A (ko) 2001-02-26

Family

ID=21806073

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020007008781A Ceased KR20010015915A (ko) 1998-02-11 1999-02-09 증강된 유전자 송달을 위한 핵산과 혈관작용제의 조합

Country Status (11)

Country Link
EP (2) EP1053025A2 (cg-RX-API-DMAC7.html)
JP (1) JP2002502885A (cg-RX-API-DMAC7.html)
KR (1) KR20010015915A (cg-RX-API-DMAC7.html)
CN (2) CN100350979C (cg-RX-API-DMAC7.html)
AU (1) AU2663799A (cg-RX-API-DMAC7.html)
CA (1) CA2320302A1 (cg-RX-API-DMAC7.html)
EA (1) EA019099B1 (cg-RX-API-DMAC7.html)
IL (1) IL137765A0 (cg-RX-API-DMAC7.html)
NZ (1) NZ545047A (cg-RX-API-DMAC7.html)
WO (1) WO1999040945A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA991102B (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6752987B1 (en) 1995-02-28 2004-06-22 The Regents Of The University Of California Adenovirus encoding human adenylylcyclase (AC) VI
US20020103147A1 (en) 1997-09-05 2002-08-01 Hammond H. Kirk Gene therapy for congestive heart failure
WO2000024415A2 (en) 1998-10-28 2000-05-04 Cornell Research Foundation, Inc. Methods for regulating angiogenesis and vascular integrity using trk receptor ligands
HK1048593A1 (zh) * 1999-11-05 2003-04-11 The Regents Of The University Of California 用於通过体内基因输送治疗心血管疾病的技术和组合物
CA2412847A1 (en) * 2000-06-30 2002-01-10 Collateral Therapeutics, Inc. Dual recombinant gene therapy compositions and methods of use
JP2005052001A (ja) * 2001-07-05 2005-03-03 Takara Bio Inc 遺伝子治療剤
EP2236153A3 (en) 2005-01-25 2012-08-22 Five Prime Therapeutics, Inc. Compositons and methods for treating cardiac conditions
PL2044199T3 (pl) * 2006-07-25 2013-04-30 Celladon Corp Przedłużony, podawany z prądem krwi, nasierdziowy, wieńcowy wlew wektorów wirusowych na bazie wirusów towarzyszących adenowirusom, zawierający SERCA2a do terapii genowej
JP5290290B2 (ja) 2007-07-18 2013-09-18 シルク・ロード・メディカル・インコーポレイテッド 頚動脈血流の逆流を確立する方法およびシステム
EP2244740A1 (en) 2008-02-19 2010-11-03 Celladon Corporation Compositions for enhanced uptake of viral vectors in the myocardium
US20130096500A1 (en) * 2011-07-07 2013-04-18 Gabor Rubanyi Nucleic acid based cardiovascular therapeutics
WO2014160887A2 (en) * 2013-03-28 2014-10-02 Silk Road Medical, Inc. Methods and systems for establishing retrograde carotid arterial blood flow
WO2019089385A1 (en) 2017-11-02 2019-05-09 Silk Road Medical, Inc. Fenestrated sheath for embolic protection during transcarotid carotid artery revascularization

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6100242A (en) * 1995-02-28 2000-08-08 The Regents Of The University Of California Gene therapies for enhancing cardiac function
US5869230A (en) * 1995-03-30 1999-02-09 Beth Israel Hospital Association Gene transfer into the kidney
WO1999017807A1 (en) * 1997-10-08 1999-04-15 Cobra Therapeutics Ltd. Use of a vasoactive compound in the enhancement of gene delivery
WO1999018792A1 (en) * 1997-10-10 1999-04-22 Johns Hopkins University Gene delivery compositions and methods

Also Published As

Publication number Publication date
CA2320302A1 (en) 1999-08-19
WO1999040945A2 (en) 1999-08-19
ZA991102B (en) 2000-03-31
IL137765A0 (en) 2001-10-31
WO1999040945A3 (en) 1999-09-30
EP1695719A1 (en) 2006-08-30
CN101186928A (zh) 2008-05-28
CN1301181A (zh) 2001-06-27
CN100350979C (zh) 2007-11-28
JP2002502885A (ja) 2002-01-29
EA200000828A1 (ru) 2001-02-26
AU2663799A (en) 1999-08-30
EA019099B1 (ru) 2014-01-30
EP1053025A2 (en) 2000-11-22
NZ545047A (en) 2009-05-31

Similar Documents

Publication Publication Date Title
US5792453A (en) Gene transfer-mediated angiogenesis therapy
US6174871B1 (en) Gene therapies for enhancing cardiac function
US20030148968A1 (en) Techniques and compositions for treating cardiovascular disease by in vivo gene delivery
AU784392B2 (en) Techniques and compositions for treating cardiovascular disease by in vivo gene delivery
CA2289600C (en) Techniques and compositions for treating heart failure and ventricular remodeling by in vivo delivery of angiogenic transgenes
CN100350979C (zh) 核酸和血管活性剂相组合用于加强的基因投递
CA2412847A1 (en) Dual recombinant gene therapy compositions and methods of use
AU2006200170B2 (en) Combination of a nucleic acid and a vasoactive agent for enhanced gene delivery
AU706050C (en) Gene transfer-mediated angiogenesis therapy
HK1094944A (en) Combination of a nucleic acid and a vasoactive agent for enhanced gene delivery
AU2006235836A1 (en) Gene transfer-mediated angiogenesis therapy
AU4754199A (en) Gene transfer-mediated angiogenesis therapy
HK1008979B (en) Gene transfer-mediated angiogenesis therapy

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20000811

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20040205

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20050929

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20070214

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20050929

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I